Responses
Scientific Abstracts
Rheumatoid arthritis - prognosis, predictors and outcome
SAT0006 No Differences in Patient-Reported Outcomes by Methotrexate Dose Among Early Rheumatoid Arthritis Patients Treated Concomitantly with Adalimumab: Results from the Concerto Trial
Compose a Response to This Article
Other responses
No responses have been published for this article.